WebGet BioCryst Pharmaceuticals Inc (BCRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Web19 hours ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for BioCryst Pharmaceuticals (BCRX)
BioCryst Pharmaceuticals Inc (BCRX) Stock Price & News
WebReal time BioCryst Pharmaceuticals (BCRX) stock price quote, stock graph, news & analysis. WebFind the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Salarius Pharmaceuticals, Inc. (SLRX) stock quote, history, news … Interactive Chart for BioCryst Pharmaceuticals, Inc. (BCRX), analyze … Discover historical prices for BCRX stock on Yahoo Finance. View daily, weekly or … Conversations - BioCryst Pharmaceuticals, Inc. (BCRX) Stock Price, News, Quote ... BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) … Find out all the key statistics for BioCryst Pharmaceuticals, Inc. (BCRX), including … See BioCryst Pharmaceuticals, Inc. (BCRX) stock analyst estimates, including … BioCryst Pharmaceuticals, Inc. 4505 Emperor Boulevard Suite 200 Durham, … Find out the direct holders, institutional holders and mutual fund holders for … View the basic BCRX option chain and compare options of BioCryst … blood tests cervical dystonia
BCRX - BioCryst Pharmaceuticals, Inc. Stock Price and Quote
WebBioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous … WebWhy BioCryst Stock Lost Nearly 4% of Its Value Today. Motley Fool. 03:00PM: BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript. Motley Fool. 08:25AM: BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Lags Revenue Estimates. ... Real-time quotes, advanced visualizations, backtesting, and much more. ... WebFeb 6, 2024 · The options have an exercise price of $10.55 per share, which is equal to the closing price of BioCryst common stock on the grant date. free directives